Too Much of a Good Thing? Overdiagnosis, or Overestimating Risk in Preventive Genomic Screening
Authors:
- 27 September 2018
- journal article
- editorial
- Published by Taylor & Francis in Personalized Medicine
- Vol. 15 (5) , 343-346
Abstract
No abstract availableKeywords
Funding Information
- National Human Genome Research Institute (P50 HG004488)
- Center for Genomics and Society’ (6/2013–5/2018)
This publication has 18 references indexed in Scilit:
- Is It Ethical to Test Apparently “Healthy” Children for Autosomal Dominant Polycystic Kidney Disease and Risk Medicalizing Thousands?Frontiers in Pediatrics, 2018
- Overdiagnosis across medical disciplines: a scoping reviewBMJ Open, 2017
- Empowerment Failure: How Shortcomings in Physician Communication Unwittingly Undermine Patient AutonomyThe American Journal of Bioethics, 2017
- Mapping the drivers of overdiagnosis to potential solutionsBMJ, 2017
- Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findingsGenetics in Medicine, 2016
- The promise and peril of genomic screening in the general populationGenetics in Medicine, 2016
- Preventive Genomic Sequencing in the General Population: Do PGS Fly?The American Journal of Bioethics, 2015
- Diagnosing overdiagnosis: conceptual challenges and suggested solutionsEuropean Journal of Epidemiology, 2014
- Overdiagnosis and Overtreatment of Prostate CancerEuropean Urology, 2014
- Overdiagnosis in CancerJNCI: Journal of the National Cancer Institute, 2010